Scientific watch for new therapies

Presentation of our Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies.

Produced by Synergyx Conseils Inc.

This study was carried out with financial support from Takeda, Pfizer and Vertex.

Consult the document

. - 1,53 MB

Documents

We suggest

Leviers de compétitivité à l’échelle mondiale

Découvrez le positionnement de Montréal en comparatif à 8 autres pôles internationaux à succès. Vous y dénicherez les facteurs clés de succès et les meilleures pratique...

Presentation of the Rare Disease Strategic Action Plan 2022

Montreal InVivo has created a Rare Disease Project Committee, representing the entire ecosystem, to propose a national plan! The presentation highlights the need for rare diseas...

Data sheets

Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies

Documents

We suggest

Studies and analysis

Leviers de compétitivité à l’échelle mondiale

Briefs and consultations

Presentation of the Rare Disease Strategic Action Plan 2022

Rare Disease Niche Study – Executive Summary 2021

Data sheets

Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies

Documents

We suggest

Studies and analysis

Leviers de compétitivité à l’échelle mondiale

Briefs and consultations

Presentation of the Rare Disease Strategic Action Plan 2022

Rare Disease Niche Study – Executive Summary 2021

Subscribe to our newsletters

Stay informed of the industry’s breaking news by subscribing to our different type of newsletters